Andrew J. Murphy, EVP Research at REGENERON PHARMACEUTICALS, INC. (REGN), sold 15,800 shares at $336.78 ($5.4M) on 2020-01-27, disclosed to the SEC on 2020-01-28.
Open-market sale of $5.4M REGN by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $336.78 | 200 | $67K | 1.3% |
| 2 | $337.46 | 270 | $91K | 1.7% |
| 3 | $337.46 | 270 | $91K | 1.7% |
| 4 | $338.54 | 712 | $241K | 4.5% |
| 5 | $338.54 | 712 | $241K | 4.5% |
| 6 | $339.37 | 567 |
| $192K |
| 3.6% |
| 7 | $339.37 | 567 | $192K | 3.6% |
| 8 | $340.56 | 1,355 | $461K | 8.6% |
| 9 | $340.56 | 1,355 | $461K | 8.6% |
| 10 | $341.58 | 3,283 | $1.1M | 20.8% |
| 11 | $341.58 | 3,283 | $1.1M | 20.8% |
| 12 | $342.44 | 1,399 | $479K | 8.9% |
| 13 | $342.44 | 1,399 | $479K | 8.9% |
| 14 | $343.02 | 214 | $73K | 1.4% |
| 15 | $343.02 | 214 | $73K | 1.4% |
| Total | $340.96 avg | 15,800 | $5.4M | 100% |
| Filing → |
| REGN | SELL | 2024-03-15 | $11.0M | — | Filing → |
| REGN | SELL | 2023-12-06 | $10.6M | — | Filing → |
| REGN | SELL | 2023-11-15 | $10.3M | — | Filing → |